Cannabinoider til behandling af neuropatiske smerter

Lasse Østergaard Andersen, Thomas Peter Enggaard, Jette Højsted

    Abstract

    Pharmacological treatment of neuropathic pain is associated with side effects and limited efficacy. Recently, the interest in cannabis-based medicine has led to legalisation of medical cannabis in some countries. The aim of this review is to evaluate the evidence of cannabinoids in neuropathic pain. Seventeen trials were identified; eight reported an analgesic efficacy of cannabis-based medicine, and the remaining trials showed no analgesic efficacy. Conclusions were limited by design of studies and short duration of treatment. Overall, the reduction in pain was minimal.

    Bidragets oversatte titelCannabinoids for neuropathic pain management
    OriginalsprogDansk
    TidsskriftUgeskrift for Laeger
    Vol/bind180
    Udgave nummer9
    Sider (fra-til)V08170602
    ISSN0041-5782
    StatusUdgivet - 26 feb. 2018

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Cannabinoider til behandling af neuropatiske smerter'. Sammen danner de et unikt fingeraftryk.

    Citationsformater